Schubert and coworkers [11] reported that continuous injections of human TNF receptor p75-IgG-Fc fusion protein (etanercept) from days 0 to 9 completely protected against the development of arthritis in GPI-induced arthritis. This evidence concerns the gene TNFRSF1B and Arthritis.